Evidence text
Paper-level observation
The dose-dependent cell viability of PS14-treated cells are as follows: 5 µM, 94.4 ± 2.66%; 10 µM, 87.31 ± 4%; 15 µM, 87.25 ± 7.21%; 20 µM, 84.44 ± 3.89% and 25 µM, 89.57± 2.39% (Figure 1).
textConfidence: medium
Assay observation
Source publication
Anti-Cancer and Anti-Inflammatory Activities of a Short Molecule, PS14 Derived from the Virulent Cellulose Binding Domain of Aphanomyces invadans, on Human Laryngeal Epithelial Cells and an In Vivo Zebrafish Embryo Model
Molecules · 2022
Related peptide identities
Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.